Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent ... older, polysaccharide-based jab Pneumovax 23.

The rivalry between Pfizer and MSD in pneumococcal vaccines ... an older shot called Pneumovax 23, which covers 23 serotypes, but is based on an older polysaccharide technology that does not ...

Healthcare providers, public health officials and policymakers need to develop a greater understanding of the serious health impact of pneumococcal disease in elderly adults. In addition to ...

The pneumococcal polysaccharide vaccine (PPV) is currently recommended for older adults and high-risk subjects, including patients with chronic obstructive pulmonary disease (COPD) and asthma.

Page Six may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. While Page Six staffers have tested plenty of ...

Pneumococcal pneumonia is particularly prevalent in older adults, and here, pneumonia is still associated with significant mortality despite the widespread use of pneumococcal vaccination in middleand ...

300003.SZ Lepu Medical Technology (Beijing) Co., Ltd.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Polysaccharides serve as stores of energy, as in glycogen (branched polysaccharide of glucose), and as a structural component of bacterial cell walls, as in cellulose (linear polysaccharide of ...